Debra  King net worth and biography

Debra King Biography and Net Worth

Vice President, Chief Digital and Information Officer of Stryker

Debra King became Vice President, Chief Digital Information Officer in May 2025.

Debra is responsible for overseeing our global IT strategy and advancing digital innovation to enhance value for our customers.

Prior to joining us, Debra served as the Chief Technology Officer at Bunge for two years and as the Chief Information Officer at Corteva, Inc., from 2017 – 2021. Prior to her executive leadership roles, Debra had extensive experience in driving technology strategy to deliver business value from her tenure at Pfizer, Inc., and by working across industry sectors in technology consulting.

Debra holds a bachelor's degree in computer science from Yeshiva University. ODFL), and she has served on numerous advisory boards, including being a former board member of the non-profit organisation, NPower.

What is Debra King's net worth?

The estimated net worth of Debra King is at least $2.06 million as of August 18th, 2026. Ms. King owns 6,210 shares of Stryker stock worth more than $2,061,447 as of August 19th. This net worth estimate does not reflect any other investments that Ms. King may own. Learn More about Debra King's net worth.

How do I contact Debra King?

The corporate mailing address for Ms. King and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Debra King's contact information.

Has Debra King been buying or selling shares of Stryker?

During the last quarter, Debra King has sold $277,783.80 in shares of Stryker stock. Most recently, Debra King sold 826 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a transaction totalling $277,783.80. Following the completion of the sale, the insider now directly owns 6,210 shares of the company's stock, valued at $2,088,423. Learn More on Debra King's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Debra King (Vice President, Chief Digital and Information Officer), Kevin Lobo (Chair and CEO), Viju Menon (Group President, Global Quality and Operations), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), Ronda Stryker (Director), and Preston Wells (Vice President, Chief Financial Officer). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 11 times. They sold a total of 1,096,708 shares worth more than $377,244,510.15. The most recent insider tranaction occured on August, 18th when insider Debra King sold 826 shares worth more than $277,783.80. Insiders at Stryker own 4.6% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 8/18/2026.

Debra King Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2026Sell826$336.30$277,783.806,210View SEC Filing Icon  
See Full Table

Debra King Buying and Selling Activity at Stryker

This chart shows Debra King's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $331.96
Low: $331.04
High: $339.24

50 Day Range

MA: $325.56
Low: $301.24
High: $352.35

2 Week Range

Now: $331.96
Low: $281.00
High: $396.86

Volume

3,179,923 shs

Average Volume

2,287,426 shs

Market Capitalization

$127.33 billion

P/E Ratio

34.40

Dividend Yield

1.04%

Beta

0.76